TDM-1 was the name given to the drug during the clinical trial. One thing that’s not any different is the price of another life extending drug, about $9800 a month and will be available in a couple of weeks. Kadcyla is a combination of a current cancer drug, Herceptin and a chemotherapy drug named DM-1. It is to be prescribed when Herceptin is no longer effective on it’s own. DM-1 on it’s own is way too toxic to delivery into the bloodstream alone. A normal course of treatment is about 9 months so you can do the math here to see at the price listed above, it is expensive. Of course they do have a hardship program where some might be able to get the drug for free. BD Saturday, February 23, 2013
FDA Approves New Late Stage Breast Cancer Drug From Roche, Life Extending Kadcyla
TDM-1 was the name given to the drug during the clinical trial. One thing that’s not any different is the price of another life extending drug, about $9800 a month and will be available in a couple of weeks. Kadcyla is a combination of a current cancer drug, Herceptin and a chemotherapy drug named DM-1. It is to be prescribed when Herceptin is no longer effective on it’s own. DM-1 on it’s own is way too toxic to delivery into the bloodstream alone. A normal course of treatment is about 9 months so you can do the math here to see at the price listed above, it is expensive. Of course they do have a hardship program where some might be able to get the drug for free. BD 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment